PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
202.31%
Revenue growth above 1.5x 6247.T's 30.96%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
157.37%
Gross profit growth above 1.5x 6247.T's 40.56%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
9397.65%
EBIT growth above 1.5x 6247.T's 114.71%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
6731.65%
Operating income growth above 1.5x 6247.T's 243.30%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
2551.92%
Net income growth above 1.5x 6247.T's 103.63%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
2619.15%
EPS growth above 1.5x 6247.T's 103.55%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
2619.15%
Diluted EPS growth above 1.5x 6247.T's 103.55%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-76.37%
Negative 10Y revenue/share CAGR while 6247.T stands at 4.19%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
232.45%
5Y revenue/share CAGR above 1.5x 6247.T's 12.58%. David Dodd would look for consistent product or market expansions fueling outperformance.
157.40%
3Y revenue/share CAGR above 1.5x 6247.T's 10.23%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
111.29%
Positive 10Y CAGR while 6247.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
548.37%
Positive 5Y CAGR while 6247.T is negative. John Neff might view this as a strong mid-term relative advantage.
159.94%
Positive short-term CAGR while 6247.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
-55.85%
Negative equity/share CAGR over 10 years while 6247.T stands at 38.89%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
60.52%
5Y equity/share CAGR above 1.5x 6247.T's 22.22%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
36.36%
3Y equity/share CAGR above 1.5x 6247.T's 0.13%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.79%
Our AR growth while 6247.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-46.20%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-18.86%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
11.64%
Positive BV/share change while 6247.T is negative. John Neff sees a clear edge over a competitor losing equity.
-36.17%
We’re deleveraging while 6247.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
298.15%
R&D growth of 298.15% while 6247.T is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
15.55%
SG&A growth well above 6247.T's 5.38%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.